It's operating in a nice little niche, specialised and boutique. Terms of the deal look like a win-win for all concerned. I like it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025